Porton Pharma Solutions (SZSE:300363) Ending Cash Position : ¥1,796 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions Ending Cash Position?

Porton Pharma Solutions's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥1,796 Mil.

Porton Pharma Solutions's quarterly Ending Cash Position declined from Sep. 2023 (¥2,105 Mil) to Dec. 2023 (¥1,956 Mil) and declined from Dec. 2023 (¥1,956 Mil) to Mar. 2024 (¥1,796 Mil).

Porton Pharma Solutions's annual Ending Cash Position increased from Dec. 2021 (¥1,077 Mil) to Dec. 2022 (¥2,515 Mil) but then declined from Dec. 2022 (¥2,515 Mil) to Dec. 2023 (¥1,956 Mil).

Porton Pharma Solutions Ending Cash Position Historical Data

The historical data trend for Porton Pharma Solutions's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Porton Pharma Solutions Ending Cash Position Chart

Porton Pharma Solutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

1,071.38

1,171.74

1,076.92

2,514.92

1,955.97

Porton Pharma Solutions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															2,574.16	2,434.08	2,105.44	1,955.97	1,796.05

Porton Pharma Solutions Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Porton Pharma Solutions's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2514.915	+	-558.95
	=	1,956

Porton Pharma Solutions's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1955.966	+	-159.912
	=	1,796

Porton Pharma Solutions Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Porton Pharma Solutions (SZSE:300363) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714

Website

http://www.porton.cn

Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.

Executives

Wang Zhong Neng	Executives
Yu Yong Mei	Executives
Sun Min	Executives
Ji Yao Hui	Executives
Ju Nian Feng	Directors, executives
Tan Jun	Supervisors
Xu Ai Wu	Directors, executives
Guo Yong Qing	Independent director
	Director
	Director
Ceng Hui	Supervisors
Chen Bei	Executives

Porton Pharma Solutions (SZSE:300363) Headlines

No Headlines